FDA issues update on Medtronic’s HeartWare Ventricular Assist Device system

Aug 26, 2022 - 03:35 PM
Image of family in hospital room, smiling

The Food and Drug Administration yesterday provided an update on the HeartWare Ventricular Assist Device system. These updates include new recommendations for patients and providers; information related to FDA’s actions following a June 2022 recall related to battery electrical faults; details on recent recalls conducted by Medtronic including new ways to reduce damage to controller port pins; and information on the system’s pump weld defect.

Related News Articles

Headline
AHA presses Bureau of Land Management to work with HHS, others to secure helium pipeline
The AHA last week encouraged the Bureau of Land Management to work with the Health and Human Services Assistant Secretary for Preparedness and Response,…
Headline
House passes bill to reauthorize FDA user fee programs
The House yesterday voted 392-28 to pass legislation (H.R. 7667) that would reauthorize Food and Drug Administration user fee programs, which provide funding…
Headline
FDA takes steps to expedite innovation in ethylene oxide sterilization
The Food and Drug Administration today announced a voluntary pilot program to expedite approvals of certain changes to ethylene oxide sterilization processes…
Headline
FDA approves duodenoscope with disposable part
The Food and Drug Administration Friday approved the first duodenoscope with a disposable elevator component, a part difficult to clean and reprocess. The…
Headline
CDC anticipates shortage of TB screening test
The Centers for Disease Control and Prevention this week announced an anticipated shortage of Aplisol, one of two TB skin tests licensed by the Food and…
Headline
FDA: Closure of medical device sterilization facility could prompt shortages
The Food and Drug Administration is working to prevent potential medical device shortages due to the closing of a Willowbrook, Ill., facility that sterilizes…